지원사업
학술연구/단체지원/교육 등 연구자 활동을 지속하도록 DBpia가 지원하고 있어요.
커뮤니티
연구자들이 자신의 연구와 전문성을 널리 알리고, 새로운 협력의 기회를 만들 수 있는 네트워킹 공간이에요.
논문 기본 정보
- 자료유형
- 학술저널
- 저자정보
- 발행연도
- 2010.1
- 수록면
- 180 - 184 (5page)
이용수
초록· 키워드
오류제보하기
The proper dose and schedule of sunitinib have yet to be established for patients with metastatic renal cell carcinoma (RCC) on hemodialysis. We reviewed two patients with metastatic RCC on hemodialysis who had been treated with sunitinib in Yonsei Cancer Center, Yonsei University College of Medicine. Fifty milligrams of sunitinib was administered intermittently after each hemodialysis session (3 or 4 times a week). Overall responses were partial response in both cases. Progression-free survivals were 16 and 6 months, respectively, at the time of reporting (April 2010). Both subjects tolerated the treatment.
목차
등록된 정보가 없습니다.
참고문헌 (12)
참고문헌 신청
Escudier B / 2007 / Bevacizumab plus interferon alfa-2a for treatment of metastatic renal cell carcinoma: a randomised, double-blind phase III trial / Lancet 370 : 2103 ~ 211
Escudier B / 2007 / Sorafenib in kidney cancer / Ann Oncol 18 : 90 ~ 93
Faivre S / 2006 / Safety, pharmacokinetic, and antitumor activity of SU11248, a novel oral multitarget tyrosine kinase inhibitor, in patients with cancer / J Clin Oncol 24 :
Hughson MD / 1986 / Renal neoplasia and acquired cystic kidney disease in patients receiving long-term dialysis / Arch Pathol Lab Med 110 : 592 ~ 601
Janus N / 2010 / Proposal for dosage adjustment and timing of chemotherapy in hemodialyzed patients / Ann Oncol 21 : 1395 ~ 1403
Escudier B / 2007 / Sorafenib in kidney cancer / Ann Oncol 18 : 90 ~ 93
Faivre S / 2006 / Safety, pharmacokinetic, and antitumor activity of SU11248, a novel oral multitarget tyrosine kinase inhibitor, in patients with cancer / J Clin Oncol 24 :
Hughson MD / 1986 / Renal neoplasia and acquired cystic kidney disease in patients receiving long-term dialysis / Arch Pathol Lab Med 110 : 592 ~ 601
Janus N / 2010 / Proposal for dosage adjustment and timing of chemotherapy in hemodialyzed patients / Ann Oncol 21 : 1395 ~ 1403
함께 읽어보면 좋을 논문
논문 유사도에 따라 DBpia 가 추천하는 논문입니다. 함께 보면 좋을 연관 논문을 확인해보세요!
-
Treatment Outcomes of Sunitinib Treatment in Advanced Renal Cell Carcinoma Patients: A Single Cancer Center Experience in Korea
Cancer Research and Treatment
2009 .01
-
말기 신 질환자의 혈액투석경험에 관한 현상학적 접근
재활간호학회지
2018 .06
-
Factors Prognostic for Survival in Japanese Patients Treated with Sunitinib as First-line Therapy for Metastatic Clear Cell Renal Cell Cancer
Asian Pacific journal of cancer prevention : APJCP
2015 .01
-
의료보장 형태가 혈액투석 서비스 제공에 미치는 영향에 대한 다수준 분석
예방의학회지
2010 .01
-
혈액투석
대한내과학회지
2014 .01
-
상악동 내 전이성 신세포암에 대한 Tyrosine Kinase 억제제 치료 경험 1예
대한이비인후-두경부외과학회지
2012 .01
-
Utilization of Sunitinib for Renal Cell Cancer: an Egyptian University hospital experience
Asian Pacific journal of cancer prevention : APJCP
2016 .01
-
Assessment of Therapeutic Effect of Sunitinib by $^{11}C$-Acetate PET Compared with FDG PET Imaging in a Patient with Metastatic Renal Cell Carcinoma
Nuclear medicine and molecular imaging : NMMI
2011 .01
-
혈액투석의 질 관리에 영향을 미치는 요인
대한내과학회지
2014 .01
-
신세포암의 갑상선 전이 1예
Annals of Surgical Treatment and Research
1997 .12
-
말기신질환에서 혈액투석에 따르는 좌우심실용적 및 기능변화에 관한 연구
대한핵의학회지
1985 .01
-
Cutaneous metastatic renal cell carcinoma to the scalp
Archives of craniofacial surgery : ACFS
2019 .01
이 논문의 저자 정보
최근 본 자료
댓글(0)
0